ÂÜÀòÂÒÂ×

Adam Levysohn is a seasoned executive in the pharmaceutical industry, currently serving as Vice President and Head of Global Market Access & Pricing at Ascendis Pharma. As the owner of Adam Levysohn Consulting, expertise in strategic market access has been honed. Previously, at Biogen, leadership roles included Head of Value & Access for Europe, Canada, and Partner Markets, as well as specialized oversight for Alzheimer’s Disease and Biogen Biosimilars. Additionally, Adam Levysohn contributed to the EFPIA as the Chairperson of the Biotherapeutics Group and held the position of Global Market Access Head for CV/Metabolism at Takeda Pharmaceutical Company Ltd.